Your browser doesn't support javascript.
loading
Cardiovascular adverse events in patients with hepatocellular carcinoma receiving vascular endothelial growth factor inhibitors.
Yuan, Fangzheng; Lenneman, Carrie; Krone, Ronald; Williams, Grant R; Outlaw, Darryl; Katsnelson, Michael; Lirette, Stephen.
Afiliação
  • Yuan F; Department of Pharmacy, University of Alabama at Birmingham Hospital, Birmingham, Alabama, USA.
  • Lenneman C; Department of Research, Baptist Hospitals of Southeast Texas, Beaumont, Texas, USA.
  • Krone R; Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
  • Williams GR; Division of Cardiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
  • Outlaw D; Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
  • Katsnelson M; Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
  • Lirette S; Division of Cardiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Pharmacotherapy ; 44(3): 214-223, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38009283

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Doenças Cardiovasculares / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Adult / Humans Idioma: En Revista: Pharmacotherapy Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Doenças Cardiovasculares / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Adult / Humans Idioma: En Revista: Pharmacotherapy Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos